BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17912244)

  • 1. C4.4A as a candidate marker in the diagnosis of colorectal cancer.
    Paret C; Hildebrand D; Weitz J; Kopp-Schneider A; Kuhn A; Beer A; Hautmann R; Zöller M
    Br J Cancer; 2007 Oct; 97(8):1146-56. PubMed ID: 17912244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of C4.4A at the invasive front is a novel prognostic marker for disease recurrence of colorectal cancer.
    Konishi K; Yamamoto H; Mimori K; Takemasa I; Mizushima T; Ikeda M; Sekimoto M; Matsuura N; Takao T; Doki Y; Mori M
    Cancer Sci; 2010 Oct; 101(10):2269-77. PubMed ID: 20825414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct expression of C4.4A in colorectal cancer detected by different antibodies.
    Yamamoto H; Oshiro R; Ohtsuka M; Uemura M; Haraguchi N; Nishimura J; Takemasa I; Mizushima T; Doki Y; Mori M
    Int J Oncol; 2013 Jan; 42(1):197-201. PubMed ID: 23175173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C4.4A expression is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Ohtsuka M; Yamamoto H; Masuzawa T; Takahashi H; Uemura M; Haraguchi N; Nishimura J; Hata T; Yamasaki M; Miyata H; Takemasa I; Mizushima T; Takiguchi S; Doki Y; Mori M
    Ann Surg Oncol; 2013 Aug; 20(8):2699-705. PubMed ID: 23435632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancer.
    Oshiro R; Yamamoto H; Takahashi H; Ohtsuka M; Wu X; Nishimura J; Takemasa I; Mizushima T; Ikeda M; Sekimoto M; Matsuura N; Doki Y; Mori M
    Cancer Sci; 2012 Jun; 103(6):1155-64. PubMed ID: 22404718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and diagnostic application of C4.4A protein in squamous cell carcinoma and adenocarcinoma].
    Wang W; Ding YQ; Li ZG; Han HX; Yang L
    Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):277-80. PubMed ID: 16776998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo synthesis of C4.4A in hepatocellular carcinoma promotes migration and invasion of tumor cells.
    Görtz M; Galli U; Longerich T; Zöller M; Erb U; Schemmer P
    Oncol Rep; 2017 Nov; 38(5):2697-2704. PubMed ID: 29048672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ly6 family member C4.4A binds laminins 1 and 5, associates with galectin-3 and supports cell migration.
    Paret C; Bourouba M; Beer A; Miyazaki K; Schnölzer M; Fiedler S; Zöller M
    Int J Cancer; 2005 Jul; 115(5):724-33. PubMed ID: 15729693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metastasis-associated molecule C4.4A promotes tissue invasion and anchorage independence by associating with the alpha6beta4 integrin.
    Thuma F; Ngora H; Zöller M
    Mol Oncol; 2013 Oct; 7(5):917-28. PubMed ID: 23727360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
    Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
    J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent expression of C4.4A and Tenascin-C in tumor cells relates to poor prognosis of esophageal squamous cell carcinoma.
    Ohtsuka M; Yamamoto H; Oshiro R; Takahashi H; Masuzawa T; Uemura M; Haraguchi N; Nishimura J; Hata T; Yamasaki M; Takemasa I; Miyata H; Mizushima T; Takiguchi S; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):439-46. PubMed ID: 23708783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of C4.4A is a potential independent prognostic factor for patients with gastric cancer.
    Cheng DQ; Gu XD; Li ZY; Xiang JB; Chen ZY
    Asian Pac J Cancer Prev; 2014; 15(9):3895-9. PubMed ID: 24935570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma.
    Hansen LV; Laerum OD; Illemann M; Nielsen BS; Ploug M
    Int J Cancer; 2008 Feb; 122(4):734-41. PubMed ID: 17849475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of C4.4A, a structural uPAR homolog, reflects squamous epithelial differentiation in the adult mouse and during embryogenesis.
    Kriegbaum MC; Jacobsen B; Hald A; Ploug M
    J Histochem Cytochem; 2011 Feb; 59(2):188-201. PubMed ID: 21339181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of C4.4A in precursor lesions of pulmonary adenocarcinoma and squamous cell carcinoma.
    Jacobsen B; Santoni-Rugiu E; Illemann M; Kriegbaum MC; Laerum OD; Ploug M
    Int J Cancer; 2012 Jun; 130(11):2734-9. PubMed ID: 21792890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer.
    Hansen LV; Skov BG; Ploug M; Pappot H
    Lung Cancer; 2007 Nov; 58(2):260-6. PubMed ID: 17706320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Blocking Antibodies against Novel AGR2-C4.4A Pathway Reduce Growth and Metastasis of Pancreatic Tumors and Increase Survival in Mice.
    Arumugam T; Deng D; Bover L; Wang H; Logsdon CD; Ramachandran V
    Mol Cancer Ther; 2015 Apr; 14(4):941-51. PubMed ID: 25646014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer.
    Willuda J; Linden L; Lerchen HG; Kopitz C; Stelte-Ludwig B; Pena C; Lange C; Golfier S; Kneip C; Carrigan PE; Mclean K; Schuhmacher J; von Ahsen O; Müller J; Dittmer F; Beier R; El Sheikh S; Tebbe J; Leder G; Apeler H; Jautelat R; Ziegelbauer K; Kreft B
    Mol Cancer Ther; 2017 May; 16(5):893-904. PubMed ID: 28292941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor.
    Hansen LV; Gårdsvoll H; Nielsen BS; Lund LR; Danø K; Jensen ON; Ploug M
    Biochem J; 2004 Jun; 380(Pt 3):845-57. PubMed ID: 15012588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C4.4A gene ablation is compatible with normal epidermal development and causes modest overt phenotypes.
    Kriegbaum MC; Jacobsen B; Füchtbauer A; Hansen GH; Christensen IJ; Rundsten CF; Persson M; Engelholm LH; Madsen AN; Di Meo I; Lund IK; Holst B; Kjaer A; Lærum OD; Füchtbauer EM; Ploug M
    Sci Rep; 2016 May; 6():25833. PubMed ID: 27169360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.